Abeona Therapeutics Inc vs iShares Russell 2000 ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while iShares Russell 2000 ETF trades at $301.64. Which is the better fit depends on your goals.
| ABEO | IWM | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | — |
52-Week High | $7.45 | $301.69 |
52-Week Low | $4.17 | $225.45 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →